Ipsen to buy Clementia Pharmaceuticals in deal worth up to $1.3 billion
The companies said the initial cash offer of $25 per share marked a premium of around 70 per cent to Clementia’s recent average…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.